Alison Sutter1, Matt Curtis2, Taeko Frost3. 1. Columbia University Mailman School of Public Health, 722 W 168(th) St., New York, NY 10032 United States. Electronic address: alisonsutter@gmail.com. 2. Independent Researcher, 1445 Lakeside Drive, Oakland, CA 94612 United States. Electronic address: mattcurtisnyc@gmail.com. 3. Harm Reduction Coalition, 1111 Broadway, 3rd Floor, Oakland, CA 94607 United States. Electronic address: frost@harmreduction.org.
Abstract
BACKGROUND: Drug overdose is the leading cause of accidental death in the United States (U.S.). Previous studies have found that place of drug use is associated with risks including overdose, sharing of drug use equipment, and arrest, but the research on this subject in the U.S. is limited. METHODS: Our study describes the relationship between place of drug use and health outcomes through the analysis of associations between frequent public drug use and drug-related arrest, overdose, and reuse of injection equipment. We analysed data from a cross-sectional, observational study of individuals who utilize syringe exchange services in 8 U.S. cities. Using regression analysis, we assessed associations between public drug use, demographic characteristics, and health risks. RESULTS: Half (48%) of the respondents (N = 575) reported that at least one of their top two most frequent places of drug use is a public place. Street homelessness (AOR = 17.44), unstable housing (AOR = 3.43) and being under age 30 (AOR = 1.85) were independently associated with increased odds of frequent public drug use. Frequent public drug use was associated with increased odds of past-year arrest for drug-related offenses (AOR = 1.87). CONCLUSION: Public drug use is associated with negative health and social outcomes. Increased access to harm reduction services, housing, and supervised consumption sites (SCS) interventions and a shift away from punitive approaches to drug use may reduce the some of the harms associated with public drug use.
BACKGROUND:Drug overdose is the leading cause of accidental death in the United States (U.S.). Previous studies have found that place of drug use is associated with risks including overdose, sharing of drug use equipment, and arrest, but the research on this subject in the U.S. is limited. METHODS: Our study describes the relationship between place of drug use and health outcomes through the analysis of associations between frequent public drug use and drug-related arrest, overdose, and reuse of injection equipment. We analysed data from a cross-sectional, observational study of individuals who utilize syringe exchange services in 8 U.S. cities. Using regression analysis, we assessed associations between public drug use, demographic characteristics, and health risks. RESULTS: Half (48%) of the respondents (N = 575) reported that at least one of their top two most frequent places of drug use is a public place. Street homelessness (AOR = 17.44), unstable housing (AOR = 3.43) and being under age 30 (AOR = 1.85) were independently associated with increased odds of frequent public drug use. Frequent public drug use was associated with increased odds of past-year arrest for drug-related offenses (AOR = 1.87). CONCLUSION: Public drug use is associated with negative health and social outcomes. Increased access to harm reduction services, housing, and supervised consumption sites (SCS) interventions and a shift away from punitive approaches to drug use may reduce the some of the harms associated with public drug use.
Authors: Ju Nyeong Park; Susan G Sherman; Saba Rouhani; Kenneth B Morales; Michelle McKenzie; Sean T Allen; Brandon D L Marshall; Traci C Green Journal: J Urban Health Date: 2019-06 Impact factor: 3.671
Authors: Monica Fadanelli; David H Cloud; Umedjon Ibragimov; April M Ballard; Nadya Prood; April M Young; Hannah L F Cooper Journal: Int J Drug Policy Date: 2019-11-18
Authors: Allison O'Rourke; Rebecca Hamilton White; Ju Nyeong Park; Kayla Rodriguez; Michael E Kilkenny; Susan G Sherman; Sean T Allen Journal: Harm Reduct J Date: 2019-08-31
Authors: Kirsten M A Trayner; Andrew McAuley; Norah E Palmateer; David J Goldberg; Samantha J Shepherd; Rory N Gunson; Emily J Tweed; Saket Priyadarshi; Catriona Milosevic; Sharon J Hutchinson Journal: Int J Drug Policy Date: 2020-01-22